Skip to main content

Knaster Alexander M's Form 4 filing

Privia Health Group, Inc. (PRVA) · filed May 11, 2023

Accession no.
0001493152-23-016378
Filed
May 11, 2023, 4:05 PM ET
Trade date
May 8, 2023
Filing delay
3 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $383.5M. It was filed 3 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Knaster Alexander MCIK 000130857410% Owner
Pamplona Capital Management, LLCCIK 000155491310% Owner
Pamplona Capital Partners III, L.P.CIK 000155491410% Owner
Pamplona Capital Management, LLPCIK 000155494210% Owner
Pamplona PE Investments Malta LtdCIK 000165090310% Owner
Halsted John C.CIK 000184440310% Owner
Pamplona Equity Advisors III LtdCIK 000185973110% Owner
Pamplona PE Investments II, Ltd.CIK 000191534510% Owner
Pamplona Private Equity Carryco III, L.P.CIK 000191534710% Owner
Pamplona Equity Carryco Advisors III, Ltd.CIK 000191535010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 8, 2023Common StockSSaleDisposed−17,741,723$21.62F2−$383,487,342.650Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), and in connection with a registered secondary offering and sale of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the selling stockholders listed on Schedule I to the Underwriting Agreement, PCP III sold 13,483,709 shares of Common Stock and Carryco III sold 4,258,014 shares of Common Stock at a purchase price of $21.615 per share.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)